BMP Sunstone Corporation ( 美国美华太阳石集团公司) will pay 20 million RMB ($3 million) to acquire 50% of Zhangjiakou Shengda Pharmaceutical Co., Ltd. from Beijing Penn Pharmaceutical Sci-Tech Development Co., Ltd. Eventually, BMP Sunstone intends to acquire a majority stake in Shengda. Like BMP Sunstone, Shengda focuses on the pediatric market with a special interest in antibiotics. It has SFDA approval to manufacture 76 drugs. More details...

Stock Symbol: (NSDQ: BJGP)